賴氨酰氧化酶(LOX)多克隆抗體(異硫氰酸熒光素標記)
FITC-Linked Polyclonal Antibody to Lysyl Oxidase (LOX)
Protein-Lysine 6-Oxidase
- 編號LAC580Mu81
- 物種Mus musculus (Mouse，小鼠)相同的名稱，不同的物種。
- 來源抗體標記
- Ig類型IgG
- 純化方式抗原特異性親和純化
- 標記物熒光素
- 原抗體-
- 緩沖液成份磷酸鹽緩沖液（pH7.4,含有0.02% NaN3和50%甘油）
- 性狀液體
- 濃度500μg/mL
- 且適物種-
- 應(yīng)用WB; IHC; ICC; IF.
如果抗體需用于流式細胞術(shù)，請參見流式抗體。 - 下載英文說明書 中文說明書
- 規(guī)格20μl100μl200μl1ml10ml
- 價格¥ 907¥ 2117¥ 3024¥ 7560¥ 30240
- 欲了解實際交易價格和更多情況，請與當?shù)亟?jīng)銷商聯(lián)系!
產(chǎn)品包裝(模擬)
產(chǎn)品包裝(模擬)
通過ISO 9001、ISO 13485質(zhì)量體系認證
特異性
該抗體是針對LOX的兔多克隆抗體。在免疫組織化學染色和免疫印跡實驗中能識別LOX。
用法
免疫印跡：0.2-2μg/mL;1:250-2500
免疫組織化學：5-20μg/mL;1:25-100
免疫細胞化學：5-20μg/mL;1:25-100
最佳稀釋倍數(shù)最終由用戶決定。
儲存
經(jīng)常使用則4°C保存。-20°C保存不超過兩年。避免反復凍融。
穩(wěn)定性
熱穩(wěn)定性以損失率顯示。損失率是由加速降解試驗決定，具體方法如下：在37°C孵育48小時，沒有顯著的降解或者沉淀產(chǎn)生。保質(zhì)期內(nèi)，在適當?shù)臈l件下存儲，損失率低于5%。
贈品
增值服務(wù)
相關(guān)產(chǎn)品
| 編號 | 適用物種：Mus musculus (Mouse，小鼠) | 應(yīng)用(僅供研究使用，不用于臨床診斷！) |
| RPC580Mu01 | 賴氨酰氧化酶(LOX)重組蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
| RPC580Mu02 | 賴氨酰氧化酶(LOX)重組蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
| PAC580Mu02 | 賴氨酰氧化酶(LOX)多克隆抗體 | WB; IHC; ICC; IP. |
| PAC580Mu01 | 賴氨酰氧化酶(LOX)多克隆抗體 | WB; IHC; ICC; IP. |
| LAC580Mu71 | 賴氨酰氧化酶(LOX)多克隆抗體(生物素標記) | WB; IHC; ICC. |
| LAC580Mu81 | 賴氨酰氧化酶(LOX)多克隆抗體(異硫氰酸熒光素標記) | WB; IHC; ICC; IF. |
| SEC580Mu | 賴氨酰氧化酶(LOX)檢測試劑盒(酶聯(lián)免疫吸附試驗法) | Enzyme-linked immunosorbent assay for Antigen Detection. |
| LMC580Mu | 賴氨酰氧化酶(LOX)等多因子檢測試劑盒(流式熒光發(fā)光法) | FLIA Kit for Antigen Detection. |
參考文獻
| 雜志 | 參考文獻 |
| American Journal of Hematology | The expression of lysyl-oxidase gene family members in myeloproliferative neoplasms.[PubMed: 23494965] |
| Current Eye Research | High Glucose Induced Differential Expression of Lysyl Oxidase and Its Isoform in ARPE-19 Cells[Pubmed: 22966818] |
| European Journal of Surgical Oncology | Evaluation of serum lysyl oxidase as a blood test for colorectal cancer [Pubmed: 24246612] |
| Vaccine | Copia autorizada por CDR[Ingentaconnect: Source] |
| Arthritis & Rheumatology | Lysyl oxidase is a potential biomarker of fibrosis in systemic sclerosis[Pubmed: 24574233] |
| Eur J Surg Oncol.? | Evaluation of serum lysyl oxidase as a blood test for colorectal cancer[Pubmed:Pmc4237001] |
| BMC Cancer. | Ionizing radiation induces tumor cell lysyl oxidase secretion[Pubmed:Pmc4223762] |
| DNA Cell Biol. | Lysyl Oxidase Genetic Variants Affect Gene Expression in Cervical Cancer[Pubmed:24945327] |
| scandinavian journal of immunology | Increased Serum Levels of the IL-33 Neutralizing sST2 in Limited Cutaneous Systemic Sclerosis[PubMed: 26095613] |
| Curr Eye Res | Correlation of Aqueous Humor Lysyl Oxidase Activity with TGF-? Levels and LOXL1 Genotype in Pseudoexfoliation[Pubmed:27116380] |
| journal of bone and mineral metabolism | LOX Fails to Substitute for RANKL in Osteoclastogenesis.[pubmed:27606829] |
| 38 | Blocking Surgically Induced Lysyl Oxidase Activity Reduces the Risk of Lung Metastases.[pubmed:28445728] |
| Molecular Medicine Reports | Lysyl oxidase is involved in synovial hyperplasia and angiogenesis in rats with collagen?induced arthritis[pubmed:28901438] |
| Revista Espa?ola de Cardiología?(English?Edition) | A Global Assessment of Circulating Prolysyl Oxidase in Nonischemic Patients With Garden-variety Heart Failure With Preserved Ejection Fraction[Pubmed:29807761] |
| Molecular?Medicine?Reports | Lysyl oxidase inhibition via β-aminoproprionitrile hampers human umbilical vein endothelial cell angiogenesis and migration in vitro[Pubmed:29393489] |
| Thyroid | Lysyl Oxidase is a key player in BRAF/MAPK pathway-driven thyroid cancer aggressiveness[Pubmed: 30398411] |
| Am J Physiol Lung Cell Mol Physiol | Lysyl Oxidase Directly Contributes to Extracellular Matrix Production and Fibrosis in Systemic Sclerosis.[Pubmed: 33026236] |
| J Am Heart Assoc | Collagen Cross?\Linking Is Associated With Cardiac Remodeling in Hypertrophic Obstructive Cardiomyopathy[33356379] |